Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells.
Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells.
复制标题
DOI:
10.1111/php.13002
复制
发表时间:
2019-01
影响因子:
3.3
通讯作者:
Hasan T
中科院分区:
文献类型:
--
作者:
Obaid G;Jin W;Bano S;Kessel D;Hasan T
With the rapidly emerging designs and applications of light-activated, photodynamic therapy (PDT)-based nanoconstructs, photonanomedicines (PNMs), an unmet need exists to establish whether conventional methods of photochemical and photophysical characterization of photosensitizers are relevant for evaluating new PNMs in order to intelligently guide their design. As a model system, we build on the clinical formulation of benzoporphyrin derivative (BPD), Visudyne®, by developing a panel of nanolipid formulations entrapping new lipidated chemical variants of BPD with differing chemical, photochemical and photophysical properties. These are 16:0 and 20:0 lysophosphocholine-BPD (16:0/20:0 BPD-PC), DSPE-PEG-BPD and BPD-cholesterol. We show that Visudyne® was the most phototoxic formulation to OVCAR-5 cells, and the least effective was liposomal DSPE-PEG-BPD. However, these differences did not match their optical, photophysical and photochemical properties, as the static BPD quenching was highest in Visudyne, which also exhibited the lowest generation of singlet oxygen production. Furthermore, we establish that OVCAR-5 cell phototoxicity also does not correlate with rates of photosensitizer photobleaching and fluorescence quantum yields in any nanolipid formulations. These findings warrant critical future studies into subcellular targets and molecular mechanisms of phototoxicity of photodynamic nanoconstructs, as more reliable prognostic surrogates for predicting efficacy in order to appropriately and intelligently guide their design. Photophysical and photochemical evaluation of photonanomedicines – light activated nanoconstructs used for photodynamic therapy (PDT) – is considered to be predictive of their potency as photodynamic agents. As a model system, we here prepare a panel of nanolipid formulations of benzoporphyrin derivative and its respective lipidated variants to assess the correlations between the photophysical and photochemical properties, and therapeutic indices in ovarian cancer cells. We concludes that photophysics and photochemistry alone are insufficient to evaluate potency and predict efficacy of emerging photonanomedicines, and that mechanistic insights into subcellular targets must be included in the evaluation process to expedite development and minimize failures.
登录
查看更多内容
影响因子:
3.3
作者:
Gollmer, Anita;Arnbjerg, Jacob;Ogilby, Peter R.
通讯作者:
Ogilby, Peter R.
影响因子:
3.1
作者:
Kiesslich, Tobias;Berlanda, Juergen;Berr, Frieder
通讯作者:
Berr, Frieder
影响因子:
14
作者:
Huang, Peng;Li, Zhiming;Cui, Daxiang
通讯作者:
Cui, Daxiang
影响因子:
3.3
作者:
Hadjur, C;Wagnieres, G;vandenBergh, H
通讯作者:
vandenBergh, H
影响因子:
8.8
作者:
Allison, B A;Pritchard, P H;Levy, J G
通讯作者:
Levy, J G